NSE: EMAMILTD | BSE: 531162

Mid-range Performer

Download real time

559.00 -11.00 (-1.93%)

27.71% Fall from 52W High

237.2K NSE+BSE Volume

NSE 26 Sep, 2025 2:14 PM (IST)

24,400.4

Market Cap

Below industry Median

0.6

Beta 1Year

Very Low volatility

Emami Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for EMAMILTD, BSE:531162 Emami Ltd.

Emami Ltd.

31 Jan 2019

559.00

-1.93%

Early signs of recovery in Kesh King & Pancharishta

Buy: Emami Ltd.

Target

Motilal Oswal

31 January 2019 business grew 7% (3.5% volume growth) while International business grew 18% YoY. EBITDA was flattish at INR2.67b (our est. for exceptional item relating to VRS compensation of INR98m) was down 0.8% YoY to INR2.1b (our est. Sales, EBITDA and PAT before amortization growth stood at 7.

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

30 Nov 2018

559.00

-1.93%

Emami Ltd. - Company Update - Power brands to drive growth

Buy: Emami Ltd.

Religare

Incorporated in 1974, Emami Limited is one of the leading and fastest growing personal and healthcare companies in India, with an enviable portfolio of over 300 household products.

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

02 Nov 2018

559.00

-1.93%

Emami Ltd Q2FY19 results Comment

Results Update: Emami Ltd.

HDFC Securities

Emami Ltd Q2FY19 results Comment Revenue increased by 2.22% to Rs. 628.02 Cr in Q2FY19 when compared to the previous quarter. Also, it grew by 0.01% when compared with Q2FY18.

Promoters unpledged 2.89% of shares in last quarter. Total pledge stands at 10.50% of promoter holdings

Emami Ltd.

01 Nov 2018

559.00

-1.93%

EMAMI 2QFY19

Buy: Emami Ltd.

Target

Chola Wealth Direct

Number of FII/FPI investors increased from 337 to 349 in Jun 2025 qtr.

Emami Ltd.

31 Oct 2018

559.00

-1.93%

Emami (2QFY19): Another blip, maintain faith. Maintain BUY

Buy: Emami Ltd.

Target

HDFC Securities

We value Emami based on P/E of 32x on Sep-20 EPS to arrive at a TP of Rs 547 (earlier Rs 561). We maintain BUY. Emami reported a weak but in-line quarter marked with seasonality, trade challenges and a heavy base (revenue/EBITDA growth of 14/15% in 2QFY18) of GST restocking. Emamis discretionary portfolio is yet to see a pick-up in consumption post demonet. Revenues were flat (exp. -2%) with 4% volume contraction (exp. -2%). EBITDA/APAT grew by -6/-12% (exp. -13/-13%).

Emami Ltd. has an average target of 763.29 from 7 brokers.

Emami Ltd.

03 Aug 2018

559.00

-1.93%

Emami Ltd Q1FY19 results Comment

Results Update: Emami Ltd.

HDFC Securities

Revenue fell by 0.42% to Rs. 614.38 Cr in Q1FY19 when compared to the previous quarter. Emami Ltd Q1FY19 results Comment

Number of FII/FPI investors increased from 337 to 349 in Jun 2025 qtr.

Emami Ltd.

03 Aug 2018

559.00

-1.93%

Emami (1QFY19): Will rise with the tide. Maintain BUY

Buy: Emami Ltd.

HDFC Securities

We value Emami based on P/E of 36x on Jun-20 EPS to arrive at a TP of Rs 634 (earlier Rs 627). We maintain BUY. Emami reported an in-line quarter marked with partial recovery, supported by an extremely favourable base (-18% in 1QFY18). Consolidated revenue grew by 19% (exp. 17%) driven by 16% volume growth (in-line). EBITDA/APAT grew by 54/42% (exp. 54/45%).

Emami Ltd. is trading below all available SMAs

Emami Ltd.

03 Aug 2018

559.00

-1.93%

EARNINGS UPDATE-EMAMI-1QFY19

Buy: Emami Ltd.

Chola Wealth Direct

Sector: FMCG /Mid-Cap | Earnings Update 1QFY19 Background: Emami is a FMCG company with niche focus on relatively under penetrated segments such as antiseptic cream, fairness cream, talcum powder, cooling oil, pain balm and pain reliever. Emami's power brands such as Navratna Oil, Boroplus Cream, Zandu & MenthoPlus Balm, Fair & Handsome, Boroplus Powder, Navratna Cool Talc, Fast Relief, SonaChandi & Zandu accounts for 75% of company's sales. Emami sales and cash PAT have grown at a CAGR of 11.4% and 11.3% respectively (FY1217). Geographical breakup of sales: North (29%), West (27%), South (23%) and East (21%). Export contributes ~10.4% of total revenue. Company has 3,000+ distributors,...

Number of FII/FPI investors increased from 337 to 349 in Jun 2025 qtr.

Emami Ltd.

02 Aug 2018

559.00

-1.93%

Seasonality affects 1QFY19 performance; outlook positive

Buy: Emami Ltd.

Motilal Oswal

Consolidated revenue on like-to-like (LTL) basis grew 19% YoY, with volume growth of 16% YoY. leading to LTL sales growth of 21%. EBITDA margin a percentage of sales (-380bp YoY) and other operating expenses were lower. Wholesale channel contributed to 40% of turnover in 1QFY19; (2) Management is confident of double-digit volume growth for the full year, particularly if the winter season is favorable. Changes to the model have resulted in 2.5%/3.2% cut in FY19/FY20E EPS. Wholesale channel normalization is highly positive for HMN. Before demand and supply-side disruption due to demonetization/GST implementation, up to 1HFY17, HMN was the most consistent performer even when other players with high rural exposure had started to slow down. Problem-solving nature of a large part of its portfolio and low penetration/ room for distribution expansion in most categories means that in a steady state environment it will outperform peers. Innovation pipeline and boost growth prospects further.

Emami Ltd. is trading below all available SMAs

Is Emami Ltd. worth buying?

225 Votes:

Buy 74.67%

Sell 17.33%

Hold 8.0%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf